A Phase II Additional Study of TAK-442 in patients with arterial thrombosis
Phase 2
- Conditions
- Arterial thrombosis
- Registration Number
- JPRN-jRCT2080221100
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients aged 30-80 years (inclusive) with onset of arterial thrombosis
Exclusion Criteria
1. Known hemorrhagic/coagulation disorder
2. Past or current history of intracranial hemorrhage.
3. Patients with a condition indicated for long-term anticoagulant therapy
4. Severe renal dysfunction or liver disorder
etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method